03/17/08 | GE Healthcare Grows #1 Market Leadership Position in Global Compact Ultrasound Industry in 2007 |
International Growth, New Product Launches and New Fields of Clinicians Using Laptop-Style Ultrasounds Fuel Growth for GE; Company Repeats as World’s Top Compact Ultrasound Provider with 50 Percent Growth, Revenues of $260 Million in 2007 | |
03/17/08 | New International Journal of Learning and Media Launched by Monterey Institute for Technology and Education and MIT Press With Grant from John D. and Catherine T. MacArthur Foundation |
Interactive quarterly Journal to Examine Changing Relationships Between Learning and Media | |
03/17/08 | GE Unit Invests in Texas, Illinois Wind Projects with Invenergy |
GE Energy Financial Services, a unit of GE, is partnering for the third time with leading global wind power developer Invenergy Wind LLC, by investing in Illinois and Texas wind farms that will produce emissions-free electricity equivalent to taking 96,000 average US cars off the road. | |
03/12/08 | Anadis Licenses Antibody Technologies from ImmuCell: Includes E. coli and C. difficile |
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA. | |
03/12/08 | Alcoa Acquires Two Aerospace Fastener Businesses to Bolster its Growing Aerospace Portfolio |
Republic and Van Petty Fasteners to Join Company's Fast-Growing Alcoa Fastening Systems Business | |
03/12/08 | ConocoPhillips Describes Business Strategies |
The company expects to spend approximately $400 million on technology in 2008, primarily to progress such technologies as reservoir imaging, steam-assisted gravity drainage, coal gasification, carbon capture and sequestration, cellulosic ethanol conversion, and refining processes. | |
03/12/08 | Sirtris Pharmaceuticals In-Licenses Key Genetic Driver of Cellular Stress Resistance and Longevity in Mammals from Robarts Research Institute |
Sirtris Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it obtained exclusive, worldwide rights from Robarts Research Institute (London, Ontario, Canada) for NamPRT (also known as Visfatin), an important genetic driver of cellular stress resistance and longevity in mammals. | |
03/10/08 | Hitachi Consulting Acquires Leading Financial Services Industry Consulting Firm JMN Associates |
Hitachi Consulting, the global consulting company of Hitachi, Ltd., announced today that it has acquired JMN Associates, a leading provider of consulting services to the financial services, real estate and insurance industries. | |
03/05/08 | PrimeGen Biotech LLC and Unidym, Inc. Form Alliance to Optimize Development of Induced Pluripotent Stem Cells |
PrimeGen Biotech LLC and Unidym Inc., a majority-owned subsidiary of Arrowhead Research Corporation, today announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine. | |
03/04/08 | Advanced Cancer Therapeutics Obtains Exclusive License to Dual Mechanism Anti-Cancer Therapeutic from the University of Louisville’s Brown Cancer Center |
Brown Cancer Center researchers Dr. Jason Chesney and Dr. John Trent discovered that 3PO inhibits a key enzyme, PFKFB3, which suppresses both sugar metabolism and cell proliferation among cancer cells. | |
[ <- 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 -> ] |